Katherine Ko
Psychiatric/Mental Health · Bellevue, WANPI 1891927000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 24.7% of the total. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$931
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$896
- Corium, LLC$388
- Takeda Pharmaceuticals U.S.A., Inc.$354
- Otsuka America Pharmaceutical, Inc.$349
- AbbVie$241
- plus $617 from 10 others
What the payments were for
- Food & beverage$3,72799%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$396
- INGREZZA$231
- REXULTI$125
- Dyanavel XR$125
- Quillivant$125
- Quillichew ER$125
How this compares
$3,776 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 26 | $176 |
| Bupropion XlBupropion Hcl | 16 | $161 |
| Risperidone | 13 | $1 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Bellevue
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
- Kelly BlissSeattle$18K
- Agnes MarambaKent$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.